Valuation (55%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.81 | 7.99 |
PEG Ratio (TTM) | -0.25 | 2.41 |
P/S Ratio (TTM) | 0.18 | 1.19 |
P/B Ratio (TTM) | 0.22 | 1.33 |
P/FCF Ratio (TTM) | N/A | 11.82 |
Price to 5YR AVG Earnings Ratio | 0.19 | 20.69 |
Price to 5YR AVG FCF Ratio | 0.29 | 4.00 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.01% | 4.66% |
ROE (TTM) | -6.07% | 15.04% |
Net Profit Margin (TTM) | -4.73% | 11.68% |
ROIC 5YR AVG | 22.21% | 9.22% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -23.05% | 3.74% | -22.99% |
Revenue | 2.51% | 31.10% | 17.06% |
Net Income | 92.42% | 18.15% | -9.55% |
Cash Flow | -25.00% | 18.69% | 16.80% |
Health (74%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.47 | 0.87 |
Quick Ratio (TTM) | 3.47 | 0.83 |
D/E Ratio (TTM) | 0.01 | 1.16 |
Interest Coverage (TTM) | 904.86 | -2.20 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 2.03 | 1.08 |
LTL to 5YR AVG FCF | 0.04 | 7.63 |
Shares Outstanding Growth 5YR AVG | 16.75% | 7.71% |